XEN45 in the Treatment of Chinese Patients With Primary Open-angle Glaucoma

NAUnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 7, 2021

Primary Completion Date

June 30, 2022

Study Completion Date

September 30, 2022

Conditions
GlaucomaGlaucoma, Open-AngleSurgery
Interventions
PROCEDURE

XEN45 gel stent implantation

The XEN45 gel implant is a collagen tube with a length of 6 mm and a diameter of 45 µm, which creates a new channel for drainage of aqueous humor by connecting the anterior chamber and the subconjunctival space. The implant is composed of porcine gelatin cross-linked with glutaraldehyde, and has good biocompatibility and tolerance.This treatment method has excellent safety and effectiveness in reducing the intraocular pressure of patients with open-angle glaucoma. At the same time, the operation is simple and safe.

Trial Locations (1)

510060

Zhognshan Ophthalmic Center, Sun Yat-sen University, Guangzhou

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Allergan

INDUSTRY

lead

Zhongshan Ophthalmic Center, Sun Yat-sen University

OTHER